Last edition
News about "Brenig Therapeutics"
Brenig Therapeutics will showcase its hybrid AI drug discovery platform at the Keystone Symposia, with Dr. Alexei Pushechnikov highlighting its collaboration with Expert Systems, Inc.
Brenig Therapeutics | 05/05/2026 | By News Bureau
Brenig Therapeutics Initiates First-in-Human Study of BT-409, Advances BT-267 Parkinson's Programme
Brenig Therapeutics has launched a first-in-human Phase I study of BT-409, a brain-selective NLRP3 inhibitor, while advancing BT-267 toward Phase 1b and Phase II studies in Parkinson’s disease.
Brenig Therapeutics | 20/01/2026 | By News Bureau | 270
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy